OTCMKTS:CBIS - Cannabis Science Stock Price, Price Target & More

$0.0620 +0.01 (+19.23 %)
(As of 04/22/2018 06:20 AM ET)
Previous Close$0.0620
Today's Range$0.0560 - $0.0630
52-Week Range$0.0311 - $0.1397
Volume12.22 million shs
Average Volume20.10 million shs
Market Capitalization$190.59 million
P/E RatioN/A
Dividend YieldN/A
Beta-3.5

About Cannabis Science (OTCMKTS:CBIS)

Cannabis Science logoCannabis Science, Inc. is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company focuses on the development of governmentally approved pharmaceuticals, including CS-TATI1, CS-S/BCC-1 and neurological therapy under study or development. The Company's subsidiaries include Cannabis Science BV and Cannabis Science International Holding BV.

Receive CBIS News and Ratings via Email

Sign-up to receive the latest news and ratings for CBIS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryCannabis
SectorN/A
SymbolOTCMKTS:CBIS
CUSIPN/A
Phone+1-888-8890888

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-151,408.60%
Return on EquityN/A
Return on Assets-590.52%

Miscellaneous

EmployeesN/A
Outstanding Shares2,520,000,000

How to Become a New Pot Stock Millionaire

Cannabis Science (OTCMKTS:CBIS) Frequently Asked Questions

What is Cannabis Science's stock symbol?

Cannabis Science trades on the OTCMKTS under the ticker symbol "CBIS."

How were Cannabis Science's earnings last quarter?

Cannabis Science Inc. (OTCMKTS:CBIS) announced its quarterly earnings data on Tuesday, July, 28th. The company reported $0.00 earnings per share for the quarter. View Cannabis Science's Earnings History.

Who are some of Cannabis Science's key competitors?

Who are Cannabis Science's key executives?

Cannabis Science's management team includes the folowing people:
  • Raymond C. Dabney, President, Chief Executive Officer, Director (Age 51)
  • Benjamin C.K. Tam, Chief Financial Officer, Secretary, Director
  • Robert Kane, Chief Operating Officer, Director (Age 40)
  • Mario Lap, Director (Age 64)

Has Cannabis Science been receiving favorable news coverage?

Media stories about CBIS stock have trended positive on Sunday, Accern Sentiment reports. The research group scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cannabis Science earned a news sentiment score of 0.44 on Accern's scale. They also assigned headlines about the company an impact score of 45.71 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Cannabis Science?

Shares of CBIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cannabis Science's stock price today?

One share of CBIS stock can currently be purchased for approximately $0.0620.

How big of a company is Cannabis Science?

Cannabis Science has a market capitalization of $190.59 million.

How can I contact Cannabis Science?

Cannabis Science's mailing address is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. The company can be reached via phone at +1-888-8890888.


MarketBeat Community Rating for Cannabis Science (CBIS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  140
MarketBeat's community ratings are surveys of what our community members think about Cannabis Science and other stocks. Vote "Outperform" if you believe CBIS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBIS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cannabis Science (OTCMKTS:CBIS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/22/2016 forward)

Earnings

Cannabis Science (OTCMKTS:CBIS) Earnings History and Estimates Chart

Earnings by Quarter for Cannabis Science (OTCMKTS:CBIS)

Cannabis Science (OTCMKTS CBIS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/17/2017Q4 2016$0.01ViewN/AView Earnings Details
7/28/2015Q3 2016($0.0030)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cannabis Science (OTCMKTS:CBIS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cannabis Science (OTCMKTS CBIS) Insider Trading and Institutional Ownership History

Insider Trading History for Cannabis Science (OTCMKTS:CBIS)

Cannabis Science (OTCMKTS CBIS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2018Benjamin C.K. TamCFOSell193,626$0.10$19,362.60View SEC Filing  
1/3/2018Robert James KaneCOOSell200,000$0.13$26,000.00View SEC Filing  
12/29/2017Robert James KaneCOOSell200,000$0.10$20,000.00View SEC Filing  
11/30/2017Robert James KaneCOOSell198,820$0.06$11,929.20View SEC Filing  
10/20/2016Robert James KaneCOOSell2,000,000$0.07$140,000.0016,537,665View SEC Filing  
10/19/2016Robert James KaneCOOSell4,000,000$0.04$160,000.0018,537,665View SEC Filing  
10/14/2016Robert James KaneCFOSell1,389,577$0.02$27,791.5421,537,665View SEC Filing  
10/10/2016Robert James KaneCFOSell1,783,475$0.02$35,669.5023,710,717View SEC Filing  
9/13/2016Robert James KaneCFOSell2,000,000$0.01$20,000.0024,710,717View SEC Filing  
5/18/2016Robert James KaneCFOSell503,345$0.02$10,066.9024,210,717View SEC Filing  
5/6/2016Robert James KaneCFOSell300,000$0.02$6,000.0024,714,062View SEC Filing  
3/31/2016Chad Steven JohnsonCOOSell500,000$0.02$10,000.0017,920,323View SEC Filing  
3/29/2016Chad Steven JohnsonCOOSell2,402,000$0.02$48,040.0018,522,323View SEC Filing  
3/21/2016Chad Steven JohnsonCOOSell483,852$0.02$9,677.04922,323View SEC Filing  
3/3/2016Chad Steven JohnsonCOOSell2,188,334$0.01$21,883.343,030,175View SEC Filing  
2/29/2016Chad Steven JohnsonCOOSell4,370,000$0.01$43,700.007,195,509View SEC Filing  
2/19/2016Chad Steven JohnsonCOOSell1,765,300$0.01$17,653.008,259,809View SEC Filing  
12/11/2015Chad Steven JohnsonCOOSell1,646,142$0.02$32,922.849,659,809View SEC Filing  
12/3/2015Chad Steven JohnsonCOOSell769,986$0.02$15,399.7211,305,951View SEC Filing  
12/2/2015Chad Steven JohnsonCOOSell1,852,239$0.02$37,044.7812,075,937View SEC Filing  
8/19/2015Chad Steven JohnsonCOOSell6,500,000$0.03$195,000.003,928,176View SEC Filing  
6/9/2015Chad Steven JohnsonCOOSell1,063,575$0.03$31,907.25View SEC Filing  
4/29/2015Chad Steven JohnsonCOOSell921,333$0.04$36,853.32View SEC Filing  
3/27/2015Chad Steven JohnsonCOOSell1,400,000$0.04$56,000.00View SEC Filing  
3/19/2015Chad Steven JohnsonCOOSell1,262,691$0.05$63,134.55View SEC Filing  
2/4/2015Chad Steven JohnsonCOOSell1,809,914$0.06$108,594.84View SEC Filing  
1/20/2015Chad Steven JohnsonCOOSell255,000$0.07$17,850.00View SEC Filing  
1/14/2015Dh BrayCEOSell1,260,750$0.06$75,645.00View SEC Filing  
1/5/2015Chad Steven JohnsonCOOSell1,600,000$0.07$112,000.00View SEC Filing  
11/20/2014Chad Steven JohnsonCOOSell433,990$0.07$30,379.30View SEC Filing  
11/14/2014Chad Steven JohnsonCOOSell251,110$0.06$15,066.60View SEC Filing  
11/3/2014Chad Steven JohnsonCOOSell400,000$0.09$36,000.00View SEC Filing  
10/31/2014Chad Steven JohnsonCOOSell750,000$0.08$60,000.00View SEC Filing  
2/13/2014Robert MelamedeMajor ShareholderSell425,800$0.17$72,386.00View SEC Filing  
2/11/2014Robert MelamedeMajor ShareholderSell779,200$0.19$148,048.00View SEC Filing  
2/6/2014Robert MelamedeMajor ShareholderSell473,300$0.25$118,325.00View SEC Filing  
2/4/2014Robert MelamedeMajor ShareholderSell659,700$0.19$125,343.00View SEC Filing  
1/30/2014Robert MelamedeMajor ShareholderSell600,200$0.19$114,038.00View SEC Filing  
1/27/2014Robert MelamedeMajor ShareholderSell525,000$0.14$73,500.00View SEC Filing  
1/22/2014Robert MelamedeMajor ShareholderSell476,500$0.11$52,415.00View SEC Filing  
1/16/2014Robert MelamedeMajor ShareholderSell425,800$0.10$42,580.00View SEC Filing  
1/13/2014Robert MelamedeMajor ShareholderSell248,800$0.12$29,856.00View SEC Filing  
1/9/2014Robert MelamedeMajor ShareholderSell170,200$0.13$22,126.00View SEC Filing  
1/7/2014Robert MelamedeMajor ShareholderSell132,200$0.07$9,254.00View SEC Filing  
1/3/2014Robert MelamedeMajor ShareholderSell83,300$0.07$5,831.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cannabis Science (OTCMKTS CBIS) News Headlines

Source:
DateHeadline
Evolab Alchemy Wins Best Vape Cartridge at 2018 Terpenes & Testing World ConferenceEvolab Alchemy Wins 'Best Vape Cartridge' at 2018 Terpenes & Testing World Conference
www.prnewswire.com - April 12 at 5:27 PM
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County ...Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County ...
globenewswire.com - April 12 at 5:27 PM
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All MultiplyCannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply
finance.yahoo.com - April 10 at 8:39 AM
CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Companys ...CURE Pharmaceutical to Participate in Hawaiian Cannabis Science Dinner & Dialogue Panel to Discuss Company's ...
globenewswire.com - March 25 at 6:09 PM
UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Companys Research on the ...UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company's Research on the ...
globenewswire.com - March 25 at 6:09 PM
Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27000 Sq. Ft., Bottling Manufacturing Facility for ... - GlobeNewswire (press release)Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27000 Sq. Ft., Bottling Manufacturing Facility for ... - GlobeNewswire (press release)
globenewswire.com - March 19 at 8:33 AM
Cannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food ContainersCannabis Science Acquires Bottle It Inc., State-of-the-Art 27,000 Sq. Ft., Bottling Manufacturing Facility for Various Bottled Waters, Energy Drinks, Vitamin Shots, Tincture Bottles, Sprays, and Various Sized Food Containers
finance.yahoo.com - March 19 at 8:33 AM
Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol ... - GlobeNewswire (press release)Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 6:54 PM
Crown Baus Announces Acquisition of Cannabia, the Worlds First Cannabis Alcoholic Beverage; Will Partner With ... - GlobeNewswire (press release)Crown Baus Announces Acquisition of Cannabia, the World's First Cannabis Alcoholic Beverage; Will Partner With ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 6:54 PM
Cannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis BeerCannabis Science Enters Multi-Billion USD Beverage Industry as it Partners with Crown Baus to Distribute Non-Alcohol Versions of Crown Baus’ Newly Acquired Cannabia, The World’s First Cannabis Beer
finance.yahoo.com - March 14 at 6:54 PM
Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing ... - GlobeNewswire (press release)Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing ... - GlobeNewswire (press release)
globenewswire.com - March 6 at 8:26 AM
Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City ApprovalsCannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals
finance.yahoo.com - March 5 at 5:43 PM
Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social ... - GlobeNewswire (press release)Cannabis Science Announces Beta Launch of iCannabinoid, a High-Tech, State-of-the-Art, Medical Marijuana Social ... - GlobeNewswire (press release)
globenewswire.com - March 1 at 8:24 AM
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles ... - GlobeNewswire (press release)Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles ... - GlobeNewswire (press release)
globenewswire.com - February 23 at 8:34 AM
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization OptionsCannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options
finance.yahoo.com - February 22 at 8:30 AM
Cannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of CancersCannabis Science Expands 5-Year Agreement With Dana-Farber Cancer Institute to Develop Cannabinoid-Based Medications and Associated Delivery Technologies for the Treatment of Cancers
finance.yahoo.com - February 2 at 3:55 PM
Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based MedicinesCannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines
finance.yahoo.com - January 31 at 3:49 PM
Cannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand OpeningsCannabis Science Prepares the Grand Openings for Its First Two Pharmacies in California and the Cannabis Science 2018 Black-Tie Gala Event Date to be Announced Right After the Grand Openings
finance.yahoo.com - January 30 at 3:50 PM
Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers JournalsCannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals
finance.yahoo.com - January 18 at 10:34 AM
Crown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems IntegrationCrown Baus Capital (OTC: CBCA) Acquires Military Grade CryptoGraphic Secure Online Communications System; Cannabis Science (OTC: CBIS) Measures Asset Backed Blockchain CryptoCurrency Usage with CryptoGraphic Systems Integration
finance.yahoo.com - January 16 at 5:08 PM
Insider Selling: Cannabis Science Inc (CBIS) CFO Sells 193,626 Shares of StockInsider Selling: Cannabis Science Inc (CBIS) CFO Sells 193,626 Shares of Stock
www.americanbankingnews.com - January 13 at 12:14 AM
Cannabis Science, Expanding its Dispensary Operation and BlockchainCannabis Science, Expanding its Dispensary Operation and Blockchain
finance.yahoo.com - January 9 at 9:41 AM
Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government ... - GlobeNewswire (press release)Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government ... - GlobeNewswire (press release)
globenewswire.com - January 5 at 4:56 PM
Data Reveals Legal Cannabis Industry Projected to Grow - PR Newswire (press release)Data Reveals Legal Cannabis Industry Projected to Grow - PR Newswire (press release)
www.prnewswire.com - January 4 at 9:38 AM
Cannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of StockCannabis Science Inc (CBIS) COO Robert James Kane Sells 200,000 Shares of Stock
www.americanbankingnews.com - January 3 at 9:52 PM
Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO ... - GlobeNewswire (press release)Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO ... - GlobeNewswire (press release)
globenewswire.com - January 3 at 8:52 AM
Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development ProgramsCannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development Programs
finance.yahoo.com - January 3 at 8:52 AM
Cannabis Science Inc (CBIS) COO Sells $20,000.00 in StockCannabis Science Inc (CBIS) COO Sells $20,000.00 in Stock
www.americanbankingnews.com - December 29 at 7:00 PM
Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries ... - GlobeNewswire (press release)Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries ... - GlobeNewswire (press release)
globenewswire.com - December 29 at 10:12 AM
Cannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries in Los Angeles on Schedule to Open for the Much-Anticipated January 2018 California Market OpeningCannabis Science Negotiates for Third Dispensary in California, With the First Two CBIS PRE ICO MMJ Dispensaries in Los Angeles on Schedule to Open for the Much-Anticipated January 2018 California Market Opening
finance.yahoo.com - December 28 at 3:49 PM
Cannabis Market Begins to Mature in Legal States - PR Newswire (press release)Cannabis Market Begins to Mature in Legal States - PR Newswire (press release)
www.prnewswire.com - December 28 at 8:31 AM
Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other ... - GlobeNewswire (press release)Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other ... - GlobeNewswire (press release)
globenewswire.com - December 22 at 9:00 PM
Cannabis Science Acquires Second PRE ICO Dispensary OTC ... - GlobeNewswire (press release)Cannabis Science Acquires Second PRE ICO Dispensary OTC ... - GlobeNewswire (press release)
globenewswire.com - December 22 at 9:00 PM
Cannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other Industry ApplicationsCannabis Science Negotiates for Major Asset Backed Blockchain Crypto Currency with Cannabis and Many Other Industry Applications
finance.yahoo.com - December 22 at 9:00 PM
Cannabis Science Acquires Second PRE ICO DispensaryCannabis Science Acquires Second PRE ICO Dispensary
finance.yahoo.com - December 20 at 9:43 AM
Cannabis Science (CBIS) vs. Miragen Therapeutics (MGEN) Head-To-Head SurveyCannabis Science (CBIS) vs. Miragen Therapeutics (MGEN) Head-To-Head Survey
www.americanbankingnews.com - December 12 at 11:38 PM
Comparing Cannabis Science (CBIS) and Miragen Therapeutics (MGEN)Comparing Cannabis Science (CBIS) and Miragen Therapeutics (MGEN)
www.americanbankingnews.com - December 12 at 5:36 AM
Cannabis Science (CBIS) versus Miragen Therapeutics (MGEN) Financial SurveyCannabis Science (CBIS) versus Miragen Therapeutics (MGEN) Financial Survey
www.americanbankingnews.com - December 11 at 6:26 PM
Cannabis Science Expands its Global Research Consortium by ... - GlobeNewswire (press release)Cannabis Science Expands its Global Research Consortium by ... - GlobeNewswire (press release)
globenewswire.com - December 11 at 5:23 PM
Cannabis Science (CBIS) & Miragen Therapeutics (MGEN) Financial AnalysisCannabis Science (CBIS) & Miragen Therapeutics (MGEN) Financial Analysis
www.americanbankingnews.com - December 10 at 7:20 PM
Analyzing BioTelemetry (BEAT) & Cannabis Science (CBIS)Analyzing BioTelemetry (BEAT) & Cannabis Science (CBIS)
www.americanbankingnews.com - December 7 at 9:24 AM
Head-To-Head Review: BioTelemetry (BEAT) and Cannabis Science (CBIS)Head-To-Head Review: BioTelemetry (BEAT) and Cannabis Science (CBIS)
www.americanbankingnews.com - December 6 at 9:38 PM
Reviewing BioTelemetry (BEAT) & Cannabis Science (CBIS)Reviewing BioTelemetry (BEAT) & Cannabis Science (CBIS)
www.americanbankingnews.com - December 5 at 1:10 AM
Robert James Kane Sells 198,820 Shares of Cannabis Science, Inc. (CBIS) StockRobert James Kane Sells 198,820 Shares of Cannabis Science, Inc. (CBIS) Stock
www.americanbankingnews.com - December 4 at 9:34 PM
CBIS Reports on November 30, 2017 TRO Hearing and Next Steps; Hearing on a Preliminary Injunction Arguments Based on Information Disregarded by San Joaquin CountyCBIS Reports on November 30, 2017 TRO Hearing and Next Steps; Hearing on a Preliminary Injunction Arguments Based on Information Disregarded by San Joaquin County
finance.yahoo.com - December 4 at 5:10 PM
CBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary ... - BenzingaCBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary ... - Benzinga
www.benzinga.com - December 1 at 5:01 PM
CBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary Restraining Order Hearing for Today, Thursday, November 30, 2017 at 3:30pm in Department 3 of the US District Courthouse, 501 I Street, Sacramento, CACBIS Reports Honorable Judge Kimberly Mueller, Appointed by Former President Barack Obama, Sets Temporary Restraining Order Hearing for Today, Thursday, November 30, 2017 at 3:30pm in Department 3 of the US District Courthouse, 501 I Street, Sacramento, CA
finance.yahoo.com - November 30 at 5:07 PM
Financial Review: BioTelemetry (BEAT) and Cannabis Science (CBIS)Financial Review: BioTelemetry (BEAT) and Cannabis Science (CBIS)
www.americanbankingnews.com - November 29 at 7:30 AM
Cannabis Science, Inc. Announces the Nearing Completion of a Novel Patentable Formulary Cannabinoid Medication to Treat Asthma/COPD Overlap Syndrome and Clinical Trials to Start SoonCannabis Science, Inc. Announces the Nearing Completion of a Novel Patentable Formulary Cannabinoid Medication to Treat Asthma/COPD Overlap Syndrome and Clinical Trials to Start Soon
finance.yahoo.com - November 28 at 8:22 AM
Analyzing Signal Genetics (MGEN) & Cannabis Science (CBIS)Analyzing Signal Genetics (MGEN) & Cannabis Science (CBIS)
www.americanbankingnews.com - November 28 at 1:08 AM

SEC Filings

Cannabis Science (OTCMKTS:CBIS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Cannabis Science (OTCMKTS CBIS) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.